The assessment made available on the Peptela website does not create a doctor-patient relationship between the individual completing the assessment and Peptela. Peptela, a network of US-licensed doctors that adhere to rigorous medical protocols designed for patient safety, has established exclusionary criteria to determine if an individual does not qualify for GLP-1s. The answers an individual provides to the Peptela assessment consequently determine if the individual is screened out of eligibility for GLP-1 medication, and a Peptela clinician will meet with an individual after checkout to determine if they qualify for a prescription. Peptela clinicians retain the decision to prescribe compounded GLP-1s to patients. Compounded GLP-1s are produced in FDA-regulated facilities. Although these facilities are highly regulated, the medications are not FDA-approved or evaluated for safety, efficacy, or quality. The decision to use compounded drugs is guided by the licensed provider’s medical judgment, which is informed by a telehealth consultation and medical history. Peptela does not produce compounded medications, and individuals may receive medication that looks different than what is portrayed on the website.